Skip to main content

From Monkey to Man: The Epidemiologic Evidence of an Association Between Simian Virus 40 and Malignancy

  • Chapter
Book cover Malignant Mesothelioma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Communicable Disease Center. Poliomyelitis Surveillance Report No. 248. Atlanta, GA: 1962.

    Google Scholar 

  2. Eddy BE, Borman GS, Berkley WH, Young RD. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 1961;107:191–197.

    PubMed  CAS  Google Scholar 

  3. Diamandopoulos GT. Induction of lymphocyte leukemia, lymphosarcoma, reticulum cell sarcoma and osteogenetic sarcoma in the Syrian golden hamster by ontogenetic DNA simian virus 40. J Natl Cancer Inst 1973;50:1347–1365.

    PubMed  CAS  Google Scholar 

  4. Kirschstein RL, Gerber P. Ependymomas produced after intracerebral inoculation of SV40 into newborn hamsters. Nature 1962;195:298–300.

    Article  Google Scholar 

  5. Rabson AS, O’Conor GT, Kirschstein RL, Branigan WJ. Papillary ependymomas produced in Rattus (mastomys) natalensis inoculated with vacuolating virus (SV40). J Natl Cancer Inst 1962;29:765–787.

    PubMed  CAS  Google Scholar 

  6. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142:1524–1533.

    PubMed  CAS  Google Scholar 

  7. Eddy BE, Borman GS, Grubbs G, Young RD. Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology 1962;17:65–75.

    Article  PubMed  CAS  Google Scholar 

  8. Koprowski H, et al. Transformation of cultures of human tissue infected with simian virus 40. J Cell Comp Physiol 1962;59:281–292.

    Article  Google Scholar 

  9. Gerber P, Hottle GA, Grubbs G. Inactivation of vacuolating virus (SV40) by formaldehyde. Proc Soc Exp Biol Med 1961;108:205–209.

    PubMed  CAS  Google Scholar 

  10. Shah KV, Willard S, Myers RE, et al. Experimental infections of rhesus with simian virus 40 (SV40). Proc Soc Exp Biol Med 1968;130:196–203.

    Google Scholar 

  11. Melnick JL, Stinbaugh S. Excretion of vacuolating SV40 virus (papovirus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962;109:965–968.

    PubMed  CAS  Google Scholar 

  12. Morris JA, Johnson KM, Aulisio CG, Chanock RM, Knight V. Clinical and serologic responses in volunteers given vacuolating virus (SV40) by respiratory route. Proc Soc Exp Biol Med 1961;108:56–59.

    PubMed  CAS  Google Scholar 

  13. Pan American Health Organization and World Health Organization. Field evidence in safety, topic II (B). In: Second International Conference on Live Poliovirus Vaccines. Washington, DC: 1960:113–227.

    Google Scholar 

  14. Fraumeni JF, Ederer F, Miller RW. An evaluation of the carcinogenecity of simian virus 40 in man. JAMA 1963;185:713–718.

    PubMed  Google Scholar 

  15. Fraumeni JF, Stark CR, Gold E, Lepow MC. Simian virus 40 in polio vaccine: follow-up of newborn recipients. Science 1970;167:59–60.

    PubMed  Google Scholar 

  16. Mortimer EA Jr, Lepow MC, Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 1981;305:1517–1518.

    Article  PubMed  Google Scholar 

  17. Carroll-Pankhurst C, Engels EA, Strickler HD, Goedert JJ, Wagner J, Mortimer EA. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during neonatal period. Br J Cancer 2001;85:1295–1297.

    Article  PubMed  CAS  Google Scholar 

  18. Martini F, Iaccheri L, et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from health individuals. Cancer Res 1996;56(20):4820–4825.

    PubMed  CAS  Google Scholar 

  19. Shah K, Nathanson N. Human exposure to SV40: reviews and comments. Am J Epidemiol 1976;103:1–12.

    PubMed  CAS  Google Scholar 

  20. Hammond EC. Cancer mortality in relation to SV40 in polio vaccine. Presented at the American Cancer Society Sciences Writers’ Seminar, 1966.

    Google Scholar 

  21. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229–234.

    PubMed  CAS  Google Scholar 

  22. Innis MD. Oncogenesis and poliomyelitis vaccine. Nature 1968;219:972–973.

    Article  PubMed  CAS  Google Scholar 

  23. Olin P, Giesecke J. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact in cancer incidence rates 1960–63. Dev Biol Stand 1998;4:227–233.

    Google Scholar 

  24. Geiseler E. SV40 and human brain tumors. Prog Med Virol 1990;37:211–222.

    Google Scholar 

  25. Strickler HD, Rosenberg PS, Devesa GG, Hertel J, Fraumeni JF, Goedert JJ. Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA 1998;279:292–295.

    Article  PubMed  CAS  Google Scholar 

  26. Fisher SG, Weber L, Carbone M. Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 1999;19:2173–2180.

    PubMed  CAS  Google Scholar 

  27. Strickler HD, Goedart JJ, Devesa SS, Lancy J, Fraumeni JF, Rosenberg PS. Trends in US pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst 2003;95:38–45.

    Article  PubMed  CAS  Google Scholar 

  28. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997;145:211–218.

    PubMed  CAS  Google Scholar 

  29. Stratton K, Almario DA, McCormick MC, eds. Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer. Washington, DC. Institute of Medicine, National Academies Press, 2002.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Fisher, S.G. (2005). From Monkey to Man: The Epidemiologic Evidence of an Association Between Simian Virus 40 and Malignancy. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_18

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_18

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics